Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications
- 9 December 2021
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 21 (17), 2304-2314
- https://doi.org/10.2174/1871520621666210217094839
Abstract
MiRNAs that are characterized by small non-coding RNAs orchestrate the expression of important genes involved in cancer cell development processes including apoptosis, proliferation, angiogenesis, metastasis, and drug resistance at the post-transcriptional level. Dysregulation of miR-9 in various cancers has been reported. Recently, miR-9 has been considered as a key miRNA in various malignancies. However its importance in the pathogenesis of different neoplasms is not yet well defined. Accordingly, this study was conducted in order to clarify the potential roles of miR-9 in in the development of various cancers, prognosis, and treatment approaches. We have shown that a large number of miR-9 targets play fundamental roles in carcinogenesis and that is dysregulated in various cancer cells. Our findings was found aberrant miR-9 expression in a majority of cancers. This review article, generally emphasize on the critical roles of miR-9 in cancer cell progression. Additionally, we intended to investigate the effects of down-regulation or up-regulation of miR-9 in different types of cancers. It is hoped that a good understanding of the regulatory roles of miR-9 in various cancers be helpful for using miR-9 in the clinical settings including prognosis, diagnose, and miRNA based target therapy.Keywords
This publication has 94 references indexed in Scilit:
- microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1PLOS ONE, 2013
- microRNA-9 Targets Matrix Metalloproteinase 14 to Inhibit Invasion, Metastasis, and Angiogenesis of Neuroblastoma CellsMolecular Cancer Therapeutics, 2012
- Aberrant hypermethylation ofmiR-9genes in gastric cancerEpigenetics, 2011
- The Role of the Transcription Factor CREB in Immune FunctionThe Journal of Immunology, 2010
- miRNAs in human cancerThe Journal of Pathology, 2010
- A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiationNucleic Acids Research, 2010
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasisNature, 2010
- Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancerThe Journal of Pathology, 2007
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006
- The Salvador partner Hippo promotes apoptosis and cell-cycle exit in DrosophilaNature, 2003